Harvard Bioscience, Inc. to Participate in the Sidoti Small Cap Virtual Conference
Harvard Bioscience (Nasdaq: HBIO) has announced its participation in the Sidoti Small Cap Virtual Conference on September 18th, 2024. Jim Green, Chairman and CEO, and Jennifer Cote, CFO, will represent the company with a presentation scheduled for 9:15 am ET.
The presentation will be webcast live through the investor relations section of Harvard Bioscience's website. A replay will be available shortly after the presentation concludes. Interested parties can schedule one-on-one meetings through the conference organizers.
This event provides an opportunity for investors to gain insights into Harvard Bioscience's operations and future prospects directly from its top executives.
Harvard Bioscience (Nasdaq: HBIO) ha annunciato la sua partecipazione alla Sidoti Small Cap Virtual Conference il 18 settembre 2024. Jim Green, Chairman e CEO, e Jennifer Cote, CFO, rappresenteranno l'azienda con una presentazione programmata per le 9:15 ET.
La presentazione sarà trasmessa in diretta attraverso la sezione delle relazioni con gli investitori del sito web di Harvard Bioscience. Una registrazione sarà disponibile poco dopo la conclusione della presentazione. Le parti interessate possono pianificare incontri individuali tramite gli organizzatori della conferenza.
Questo evento offre un'opportunità agli investitori di ottenere informazioni sulle operazioni e le prospettive future di Harvard Bioscience direttamente dai suoi dirigenti.
Harvard Bioscience (Nasdaq: HBIO) ha anunciado su participación en la Sidoti Small Cap Virtual Conference el 18 de septiembre de 2024. Jim Green, Presidente y CEO, y Jennifer Cote, CFO, representarán a la empresa con una presentación programada para las 9:15 am ET.
La presentación se transmitirá en vivo a través de la sección de relaciones con inversores del sitio web de Harvard Bioscience. Una grabación estará disponible poco después de que finalice la presentación. Las partes interesadas pueden concertar reuniones individuales a través de los organizadores de la conferencia.
Este evento brinda a los inversores la oportunidad de obtener información sobre las operaciones y perspectivas futuras de Harvard Bioscience directamente de sus altos ejecutivos.
하버드 바이오사이언스(Harvard Bioscience, Nasdaq: HBIO)가 Sidoti Small Cap Virtual Conference에 2024년 9월 18일 참여한다고 발표했습니다. 짐 그린(Jim Green) 회장 겸 CEO와 제니퍼 코트(Jennifer Cote) CFO가 오전 9:15 ET에 예정된 발표로 회사를 대표합니다.
발표는 하버드 바이오사이언스 웹사이트의 투자자 관계 섹션을 통해 실시간으로 방송됩니다. 발표가 끝난 후 곧바로 다시 보기 기능이 제공될 예정입니다. 관심 있는 분들은 컨퍼런스 주최 측을 통해 일대일 미팅을 예약할 수 있습니다.
이 이벤트는 투자자들이 하버드 바이오사이언스의 운영 및 향후 전망에 대해 최고 경영진으로부터 직접 통찰을 얻을 수 있는 기회를 제공합니다.
Harvard Bioscience (Nasdaq: HBIO) a annoncé sa participation à la Sidoti Small Cap Virtual Conference le 18 septembre 2024. Jim Green, Président et CEO, et Jennifer Cote, CFO, représenteront l'entreprise avec une présentation prévue pour 9h15 ET.
La présentation sera diffusée en direct via la section des relations avec les investisseurs du site web de Harvard Bioscience. Un replay sera disponible peu après la fin de la présentation. Les parties intéressées peuvent planifier des réunions individuelles via les organisateurs de la conférence.
Cette événement offre aux investisseurs l'occasion d'obtenir des informations sur les opérations et les perspectives d'avenir de Harvard Bioscience directement de ses dirigeants.
Harvard Bioscience (Nasdaq: HBIO) hat seine Teilnahme an der Sidoti Small Cap Virtual Conference am 18. September 2024 angekündigt. Jim Green, Vorsitzender und CEO, sowie Jennifer Cote, CFO, werden das Unternehmen mit einer Präsentation vertreten, die für 9:15 Uhr ET geplant ist.
Die Präsentation wird live übertragen und ist im Bereich für Investoren auf der Website von Harvard Bioscience verfügbar. Eine Aufzeichnung wird kurz nach Ende der Präsentation zur Verfügung stehen. Interessierte Parteien können über die Konferenzorganisatoren individuelle Meetings planen.
Diese Veranstaltung bietet Investoren die Möglichkeit, direkte Einblicke in die Aktivitäten und zukünftigen Perspektiven von Harvard Bioscience zu erhalten, direkt von den Führungskräften des Unternehmens.
- None.
- None.
HOLLISTON, Mass., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be participating in the Sidoti Small Cap Virtual Conference on September 18th, 2024, with a presentation time of 9:15 am ET.
The presentation will be webcast live and can be accessed through the investor relations section of the Harvard Bioscience website: https://investor.harvardbioscience.com/events-and-presentations. A replay will be available on the company’s website shortly after the presentation has concluded.
To schedule a one-on-one meeting, please contact the conference organizers directly.
About Harvard Bioscience, Inc.
Harvard Bioscience, Inc. is a leading developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, pharmaceutical and therapy discovery, bio-production and preclinical testing for pharmaceutical and therapy development. Our customers range from renowned academic institutions and government laboratories to the world’s leading pharmaceutical, biotechnology and contract research organizations. With operations in North America, Europe, and China, we sell through a combination of direct and distribution channels to customers around the world. For more information, please visit our website at www.harvardbioscience.com
Company Contact:
Harvard Bioscience
Jen Cote, Chief Financial Officer
(508) 893-3120
Investor Contacts:
Three Part Advisors
Sandy Martin / Erol Girgin / William Shelmire
HBIO@threepa.com
(214) 616-2207
FAQ
When is Harvard Bioscience (HBIO) participating in the Sidoti Small Cap Virtual Conference?
Who will be representing Harvard Bioscience (HBIO) at the Sidoti Small Cap Virtual Conference?
How can investors access Harvard Bioscience's (HBIO) presentation at the Sidoti conference?
Will there be a replay available of Harvard Bioscience's (HBIO) Sidoti conference presentation?
How can investors schedule one-on-one meetings with Harvard Bioscience (HBIO) at the Sidoti conference?
